Adimab Investors

33 investors on Angel Roster list Adimab in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States, Israel and China.

Investors are matched on the company name in their portfolio, so companies that share the name Adimab can appear together.

Investors listed
33
With verified email
55%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 33 Adimab investors

The most complete profiles first. Showing 33 of 33.

  • Adam GoulburnVerified

    Venture Capital, Investor · United States

    Series BHealth CareWellnessWomen FoundedLife Science

    Portfolio: Auris Health, Workit Health, OpenSpace, Science 37 and 81 more

    Verified email available

  • Alexandra CantleyVerified

    Venture Capital, Investor · United States

    SeedPre-SeedHealth CareWomen FoundedArtificial Intelligence (AI)Information Technology (IT)

    Portfolio: KSQ Therapeutics, Noema Pharma, Quartet Health, Notarize and 76 more

    Verified email available

  • Amy SchulmanVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedPre-SeedHealth CareWomen FoundedEnterprise SoftwareAndroid

    Portfolio: KSQ Therapeutics, Noema Pharma, Quartet Health, Notarize and 80 more

    Contact details available

  • Connor RyanVerified

    Venture Capital, Advisor, Private Equity Firm · United States

    SeedHealth CareE-commerceWellnessWomen Founded

    Portfolio: KSQ Therapeutics, Noema Pharma, Quartet Health, Notarize and 76 more

    Verified email available

  • Dave BarrettVerified

    Venture Capital, Investor · United States

    SeedPre-SeedHealth CareWomen FoundedArtificial Intelligence (AI)Information Technology (IT)

    Portfolio: KSQ Therapeutics, Noema Pharma, Quartet Health, Notarize and 84 more

    Verified email available

  • David BonitaVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 93 more

    Verified email available

  • Geoffrey HsuVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Krishna YeshwantVerified

    Venture Capital, Corporate Venture Capital, Investor · United States

    Series BHealth CareTelecommunicationsHospitalsE-commerce

    Portfolio: Pixie, Dialpad, Science 37, Synack and 90 more

    Verified email available

  • Sabrina ChiassonVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedPre-SeedHealth CareWomen FoundedEnterprise SoftwareAndroid

    Portfolio: KSQ Therapeutics, Noema Pharma, Quartet Health, Notarize and 76 more

    Verified email available

  • Alan CraneVerified

    Venture Capital · United States

    Health CareWomen FoundedArtificial Intelligence (AI)Information Technology (IT)

    Portfolio: KSQ Therapeutics, Noema Pharma, Quartet Health, Notarize and 82 more

    Verified email available

  • Ben ShawVerified

    Venture Capital · United States

    Health CareWomen FoundedEnterprise SoftwareEnergy

    Portfolio: Compass Therapeutics, Avitide, Vets First Choice, Evox Therapeutics and 27 more

    Verified email available

  • Chris PachecoVerified

    Venture Capital · United States

    Health CareWomen FoundedArtificial Intelligence (AI)Information Technology (IT)

    Portfolio: KSQ Therapeutics, Noema Pharma, Quartet Health, Notarize and 75 more

    Verified email available

  • Harold FriedmanVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedEnterprise SoftwareAndroid

    Portfolio: KSQ Therapeutics, Noema Pharma, Quartet Health, Notarize and 75 more

    Verified email available

  • Jonathan SilversteinVerified

    Private Equity Firm · United States

    Health CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Jonathan WangVerified

    Private Equity Firm · China

    Health CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Karim FarisVerified

    Venture Capital, Corporate Venture Capital · United States

    Health CareTelecommunicationsE-commerceConsumer Goods

    Portfolio: Pixie, Dialpad, Science 37, Synack and 87 more

    Verified email available

  • Mark J.Verified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedEnterprise SoftwareAndroid

    Portfolio: KSQ Therapeutics, Noema Pharma, Quartet Health, Notarize and 75 more

    Verified email available

  • Phil FerneauVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedEnterprise SoftwareAndroid

    Portfolio: Compass Therapeutics, Avitide, Vets First Choice, Evox Therapeutics and 27 more

    Verified email available

  • Rishi GuptaVerified

    Private Equity Firm · United States

    Health CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Bryce Youngren

    Venture Capital, Investor · United States

    SeedPre-SeedHealth CareWomen FoundedArtificial Intelligence (AI)Small and Medium Businesses

    Portfolio: KSQ Therapeutics, Noema Pharma, Quartet Health, Notarize and 79 more

    Contact details available

  • Carter Neild

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • Chau Khuong

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Gennao Bio, Yisheng Biopharma and 89 more

    Contact details available

  • Darren Carroll

    Venture Capital, Investor · United States

    SeedPre-SeedHealth CareWomen FoundedArtificial Intelligence (AI)Information Technology (IT)

    Portfolio: KSQ Therapeutics, Noema Pharma, Quartet Health, Notarize and 75 more

    Contact details available

  • Emily Snyder

    Venture Capital, Private Equity Firm, Investor · United States

    SeedPre-SeedHealth CareWomen FoundedEnterprise SoftwareAndroid

    Portfolio: Compass Therapeutics, Avitide, Vets First Choice, Evox Therapeutics and 27 more

    Contact details available

  • Jannah Boudreaux

    Venture Capital, Investor · United States

    SeedPre-SeedHealth CareWomen FoundedEnterprise SoftwareArtificial Intelligence (AI)

    Portfolio: KSQ Therapeutics, Noema Pharma, Quartet Health, Notarize and 75 more

    Contact details available

  • Marissa Bertorelli

    Venture Capital, Private Equity Firm, Investor · United States

    SeedPre-SeedHealth CareWomen FoundedEnterprise SoftwareAndroid

    Portfolio: KSQ Therapeutics, Noema Pharma, Quartet Health, Notarize and 75 more

    Contact details available

  • Scotland Stevens

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • Anat Naschitz

    Private Equity Firm · Israel

    Health CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • Betsabeh Madani

    Venture Capital · United States

    Health CareWomen FoundedEnterprise SoftwareEnergy

    Portfolio: Compass Therapeutics, Avitide, Vets First Choice, Evox Therapeutics and 27 more

    Contact details available

  • Brendan Hannigan

    Venture Capital · United States

    Health CareWomen FoundedArtificial Intelligence (AI)Information Technology (IT)

    Portfolio: KSQ Therapeutics, Noema Pharma, Quartet Health, Notarize and 75 more

    Contact details available

  • Erez Chimovits

    Private Equity Firm · Israel

    Health CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • Jim Weinstein

    Venture Capital · United States

    Health CareWomen FoundedArtificial Intelligence (AI)Information Technology (IT)

    Portfolio: KSQ Therapeutics, Noema Pharma, Quartet Health, Notarize and 75 more

    Contact details available

  • Jon Flint

    Venture Capital · United States

    Health CareWomen FoundedArtificial Intelligence (AI)Information Technology (IT)

    Portfolio: KSQ Therapeutics, Noema Pharma, Quartet Health, Notarize and 75 more

    Contact details available

Frequently asked questions

How many Adimab investors are on Angel Roster?

Angel Roster lists 33 Adimab investors. 18 of them (55%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (28), Private Equity Firms (18) and Corporate Venture Capital Firms (2). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Adimab investors invest in?

Among those that list a stage, the most common are Seed (15), Pre-Seed (9) and Series A (5).

Where are Adimab investors based?

Most are based in the United States (30), Israel (2) and China (1).

Which companies have Adimab investors backed?

The most-backed portfolio companies among them are Adagio Therapeutics (28), Pandion Therapeutics (26), FidoCure (20), Freenome (18) and SQZ Biotech (18).

How do I contact Adimab investors?

Create a free Angel Roster account to search and filter all 33, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.